An attenuated strain of Shigella flexneri was utilised to express viral protein (VP) 4 of rotavirus and the immunogenicity of the recombinant constructs was studied in BALB/c mice. VP4 was expressed as a fusion with maltose binding protein (MBP) in both the cytoplasm and periplasm, with a much higher level of expression occurring in the former. While all constructs induced a Shigella-specific response in mice, only the construct expressing MBP-VP4 in the cytoplasm of Shigella stimulated an immune response specific to rotavirus. This study demonstrates that Shigella can be used to deliver rotavirus antigens and induces an immune response directed towards both rotavirus and Shigella. ß
Introduction
Shigella and rotavirus both cause severe diarrhoea. Infection can prove to be fatal, and hence control of these two pathogens by vaccination has been prioritised by the World Health Organisation [1] . The majority of Shigella-related deaths are young children living in developing countries [2] . Although improved hygiene reduces the incidence of shigellosis, this is di¤cult to implement in developing countries. Conversely, rotavirus is prevalent throughout the world's population [1] , so increased sanitation will not limit disease. Hence there is a great need for e¡ective vaccines against both pathogens.
The host's immune response targets the invasive plasmid-associated antigens (Ipas) and lipopolysaccharide (LPS) of Shigella, with S. £exneri 5a LPS antibody able to protect against challenge with S. £exneri 5a [3] . In this study, we employed an attenuated strain of S. £exneri, SFL124, which has been shown to induce a protective immune response in primates. This candidate vaccine strain was well tolerated by humans, and stimulated a Shigella-speci¢c immune response [4] . S. £exneri has recently been used to stimulate an immune response to expressed foreign antigens, in addition to the response directed towards the bacterial vector itself [5] .
While antibodies to either of the outer capsid proteins of rotavirus, viral protein (VP) 4 or VP7, have been demonstrated to protect against disease [6] , VP4 has been shown to generate a heterotypic immune response [7, 8] . VP4 is involved in viral attachment to the host cell. Trypsin cleavage of VP4 increases viral infectivity by allowing the virus to directly enter cells via membrane penetration [9] . Both the amino-and carboxy-terminals of VP4 have been separately expressed in Escherichia coli, resulting in a signi¢cant antibody response [7, 11, 12] . Although rotaviral disease could be controlled by vaccination, a safe, e¡ective and inexpensive vaccine is required [10] .
It has recently been shown that VP4 is stable and antigenic in E. coli when expressed as a fusion protein with maltose binding protein (MBP) [13] . In this paper we report the expression of MBP-VP4 by a candidate vaccine strain of S. £exneri and show its ability to stimulate an immune response against both Shigella and rotavirus in mice.
Materials and methods

Bacterial strains and plasmids
E. coli strain JM109 was the initial carrier of all recombinant plasmids [14] . SFL124, an attenuated Shigella £exneri strain [2] , was the ¢nal host for the recombinant plasmids. Bacteria were grown in Luria-Bertani broth, supplemented with ampicillin (100 Wg ml 31 ) when necessary. All recombinant plasmids were derived from either pMAL-c or pMAL-p (New England Biolabs). The pMAL-c plasmid expresses MBP fusion in the cytoplasm while pMAL-p directs the MBP fusion to the periplasm.
PCR
The primers used were the following: 5P-CGAG-GATCCATGGCTTCGCTCATTTAT-3P (upstream primer) and 5P-CGCGTCGACTCCTCTAGAAAT-TGCTTA-3P (downstream primer), the BamHI and SalI sites (underlined) were introduced for cloning. The template DNA consisted of the gene encoding VP4 of a simian rotavirus strain cloned into pGEM3Z. The 50-Wl reaction mixture contained 0.2 mM dNTPs, 1.0 WM of each primer, 5 ng of template DNA and 0.5 unit of Taq DNA polymerase. Ampli¢cation conditions consisted of 30 cycles of 30 s at 95³C, 1 min at 54³C and 1.5 min at 72³C.
Bacterial growth curves
Overnight cultures were subcultured (1:20) in fresh medium and grown for 2 h. Expression of the MBP fusion protein was then induced by addition of 40 mM isopropyl-L-D-thiogalactoside (IPTG) and the cultures were grown for another 3 h. Culture samples were taken throughout the 5-h growth period, harvested, resuspended in PBS and the optical density (OD) at 595 nm measured. Samples were serially diluted and plated out to determine the number of colony forming units (cfu).
SDS-PAGE and Western blotting
Overnight cultures were subcultured (1:20), incubated for 2 h, induced with 40 mM IPTG and incubated for an additional 2 h. The cells were harvested, resuspended in sample bu¡er and heated to 100³C for 10 min. Electrophoresis was performed using a 9% resolving gel and Coomassie blue was used to stain the gels.
Proteins separated via SDS-PAGE were transferred electrophoretically onto a nitrocellulose membrane. The membrane was blocked in PBS containing 5% skim milk for 1 h and then incubated for 2 h with the primary antibody, polyclonal rabbit antisimian rotavirus, diluted 1:1000. The membrane was then washed and incubated for 1.5 h with the secondary antibody, anti-rabbit IgG peroxidase conjugate (Sigma), diluted 1:12 000. The binding of antibodies to the membrane was visualised using a chemiluminescent detection kit (Boehringer Mannheim).
Immunisation of mice and ELISA
Overnight cultures were subcultured (1:20), grown for 2 h, induced with 40 mM IPTG and grown for a further 2 h. The cultures were harvested and resuspended in PBS. Six-week-old female BALB/c mice were immunised intranasally with 30 Wl of bacterial suspension (containing 5U10 6 cfu) on days 1 and 10. Serum samples were taken prior to immunisation (day 0) and every week thereafter for 4 weeks.
Reactivity of pooled immune serum with rotavirus or serotype Y-speci¢c LPS (S. £exneri) was detected using ELISA. Plates were coated with 100 Wl of LPS (kindly provided by the Karolinska Institute, Huddinge Hospital, Huddinge, Sweden) in sodium borate saline (10 mg ml 31 ), or 3U10 7 pfu ml 31 (100 Wl) of rhesus rotavirus particles (kindly provided by R.F. Bishop, Royal Children's Hospital, Melbourne, Australia) in sodium borate saline and incubated overnight at 4³C. The plates were rinsed and blocked for 1 h with PBS containing 5% skim milk. Serum was serially diluted and added as the primary antibody. The plates were incubated for 2 h and rinsed. The secondary antibody, sheep anti-mouse IgG conjugated with horseradish peroxidase (Silenus) (diluted 1:1000), was added, the plates were incubated for an additional 1 h and then rinsed. Detection of secondary antibody binding was performed by adding peroxidase substrate. The OD of samples was read at 490 nm. Experiments were performed in duplicate and the OD readings averaged.
Results
Cloning and expression of VP4 in S. £exneri
Oligonucleotides were designed from the sequence of the VP4-encoding gene to provide an in-frame fusion with the malE gene in pMAL-c and pMALp. The VP4 PCR product was digested with BamHI and SalI, ligated into the vectors and transformed into E. coli JM109. BamHI and SalI double restriction digests con¢rmed that both plasmids pNV686 (pMAL-c/VP4) and pNV687 (pMAL-p/VP4) carried the VP4-encoding gene. The E. coli JM109 strains carrying pNV686, pNV687, pMAL-c and pMAL-p were denoted B781, B782, B786 and B787, respectively. SDS-PAGE con¢rmed that recombinant strains B781 and B782 express the 130-kDa MBP-VP4 fusion protein when induced by IPTG. In the controls, B786 and B787, IPTG induced expression of the 43-kDa MBP (data not shown).
Plasmids pNV686, pNV687, pMAL-c and pMALp were transformed into SFL124. The strains carrying plasmids pNV686, pNV687, pMAL-c and pMAL-p were denoted SFL1236, SFL1238, SFL1240 and SFL1241, respectively. Western blotting was performed to detect the expression of the MBP-VP4 fusion protein. Strains SFL1236 and SFL1238 expressed the 130-kDa MBP-VP4, which was absent in the control strains SFL1240 and SFL1241. The SFL1236 strain (pMAL-c/VP4) had much higher expression of the MBP-VP4 fusion, in comparison to the SFL1238 strain (pMAL-p/VP4) (Fig. 1) . A similar trend was observed in E. coli experiments (data not shown). The SFL1236 strain had additional protein bands bound by the antibody (Fig. 1 ). Presumably these bands represent MBP-VP4 degradative products.
In vitro growth of S. £exneri expressing MBP-VP4 fusion
Growth curves were constructed to study the e¡ect of MBP-VP4 on bacterial growth and to allow the level of bacteria to be quanti¢ed for immunisation. Overnight cultures of the SFL1236 (pMAL-c/VP4), SFL1238 (pMAL-p/VP4), SFL1240 (pMAL-c) and SFL1241 (pMAL-p) strains were grown to exponential phase and induced with IPTG. Addition of IPTG had no signi¢cant e¡ect on the control strains, Fig. 3 . Rotavirus-speci¢c antibody response in mice immunised with two doses of SFL1236. Endpoint antibody titre is the reciprocal of the lowest dilution of the serum which gave an OD reading at least 0.1 unit above that for the control sample. Fig. 4 . Shigella-speci¢c antibody response in mice immunised with two doses of SFL1236, SFL1238, SFL1240 or SFL1241. Endpoint antibody titre is the reciprocal of the lowest dilution of the serum which gave an OD reading at least 0.1 unit above that for the sample taken before immunisation.
however, induction of MBP-VP4 production by SFL1236 and SFL1238 led to a reduction in viable bacteria, especially in the case of the latter (Fig. 2). 
Immunogenicity of VP4-expressing S. £exneri
Mice were immunised with 5U10 6 cfu on days 1 and 10 and serum samples were collected over the 4-week period following the initial immunisation. A rotavirus-speci¢c humoral immune response was detected in the pooled sera of the mice immunised with the SFL1236 strain (pMAL-c/VP4). This peaked 3 weeks after the initial immunisation (Fig. 3) . No rotavirus response was detected in mice given the SFL1238 (pMAL-p/VP4) strain. The sera collected from all groups of mice reacted with LPS, since all mice were immunised with S. £exneri, with the titre increasing over the 4-week interval (Fig. 4) . The antibody response towards LPS was greater for mice immunised with the SFL1236 (pMAL-c/VP4) and SFL1240 (pMAL-c) strains, in comparison to the response of SFL1238 (pMAL-p/VP4)-and SFL1241 (pMAL-p)-infected mice.
Discussion
The capacity for the induction of a heterotypic immune response, and the previously shown immunogenicity of VP4 [11, 12] , led to the selection of VP4 for this study. VP4 was expressed as a fusion with MBP in both the cytoplasm and periplasm of S. £exneri in order to maintain the antigenicity and stability of the viral protein. The expression of the MBP-VP4 fusion was much greater in the SFL1236 strain (pMAL-c/VP4) than the SFL1238 strain (pMAL-p/VP4). This di¡erence in expression may be related to a dysfunction of the membrane transport mechanisms which could inhibit the tra¤c of MBP-VP4 into the periplasm. It has been demonstrated that the e¤ciency of membrane translocation of certain fusion proteins is inversely proportional to the size of the molecule [15] . Thus the MBP-VP4 fusion may be too large for e¤cient transportation, and as a consequence may be degraded. The tertiary structure of the fusion protein may also a¡ect its membrane translocation, since unfolded proteins become jammed in the cytoplasmic membrane during secretion. This blockage prevents transportation of proteins out of the cytoplasm, resulting in the death of the bacterium [16, 17] . In this study, IPTG induction of the SFL1236 (pMAL-c/VP4) and SFL1238 (pMAL-p/VP4) strains led to the expression of MBP-VP4, however, this was accompanied by a reduction in viability. A much more dramatic drop in bacterial viability occurred with SFL1238. This difference between the SFL1236 and SFL1238 strains could be due to the fact that the protein fusion can potentially block the transport machinery of the bacterium.
Epitope abundance, as opposed to cellular compartment, has been demonstrated to be the critical factor for induction of an immune response in studies with both E. coli and Salmonella typhimurium [18] . The results of the present study suggest that the quantity of antigen is in£uential since the SFL1236 strain (pMAL-c/VP4), which had much higher expression of the MBP-VP4 fusion, was shown to be immunogenic in mice, in contrast to the SFL1238 strain (pMAL-p/VP4). Thus it would be of interest to determine whether the ability of Shigella to generate an immune response is a¡ected by compartmentalisation. VP5 and VP8 result from trypsin cleavage of VP4, therefore, the smaller size of these proteins may promote more e¤cient transport and equal expression in the cytoplasm and periplasm. Immunisation with constructs expressing the cleavage products may, in turn, determine whether cytoplasmic or periplasmic expression of rotaviral proteins by Shigella is more e¤cient at inducing an immune response.
In this study, only mice immunised intranasally with the SFL1236 strain (pMAL-c/VP4) developed a rotavirus-speci¢c antibody response. The absence of a detectable response in the SFL1238 (pMAL-p/ VP4)-infected mice may be attributed to the reduced expression of MBP-VP4 by the SFL1238 strain. Alternatively, the bacteria may be less viable due to possible di¤culties in the transportation of MBP-VP4 into the periplasm (as discussed earlier), and die before they are able to invade the murine pulmonary epithelium. This would also explain the reduced immune response speci¢c to Shigella LPS.
The development of a well tolerated heterotypic rotavirus vaccine would substantially reduce the world-wide incidence of viral gastroenteritis. The re-sults of the SFL1236 strain demonstrate for the ¢rst time that immunisation with an attenuated strain of Shigella expressing a rotaviral antigen is able to generate a speci¢c humoral immune response against both rotavirus and the bacterial vector. Therefore the Shigella-rotavirus constructs of this study have potential with respect to the future development of an e¡ective rotavirus vaccine.
